Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f23c51e91c2880e36543b4e213dd25b6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0665 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0667 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0668 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
filingDate |
2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f92f25cf4eb23e3b2825e85ec92a5cd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d22e1bf31642794dfd3583830a7dff26 |
publicationDate |
2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018021879-A1 |
titleOfInvention |
Method for producing mesenchymal stem cells that inhibit proliferation of cancer cells |
abstract |
The present invention relates to a culture medium composition for producing mesenchymal stem cells for cancer treatment which inhibit proliferation of cancer cells while maintaining the differentiation potency and activity, and a method for producing mesenchymal stem cells for cancer treatment using the composition and, more specifically, to a culture medium composition for producing mesenchymal stem cells containing vitamin C and aspirin and having an improved ability to inhibit proliferation of cancer cells, and a method for producing mesenchymal stem cells for cancer treatment using the composition. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210075911-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019240559-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021118325-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102317328-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102233568-B1 |
priorityDate |
2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |